These results demonstrate that MKP-2 is upregulated in liver tissue in humans with obesity and fatty liver disease and in insulin-responsive tissues in mice with obesity and may contribute to the development of obesity and NAFLD/NASH. This evidence concerns the gene DUSP4 and metabolic dysfunction-associated steatohepatitis.